CATABASIS PHARMACEUTICALS INC 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Oct 5, 2016
Insider Transaction Report
Form 4
Nichols Andrew John
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2016-10-03+13,000→ 13,000 totalExercise: $5.79Exp: 2026-10-02→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]This option was granted on October 3, 2016 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of October 1, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.